Frontier Bio
Hayward
About Frontier Bio
Frontier Bio is creating lab-grown human tissues as an ethical replacement for animal studies and is setting the stage to eliminate the organ transplant waitlist.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.2M
- Last round: Series Unknown (Aug 2025)
- Website: frontierbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/frontier-bio-107312 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.